New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

Ardelyx, Inc.

Contributing Author

Recent Articles by Ardelyx, Inc.

Jan-28	First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA ARDX GlobeNewswire
Jan-08	Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook ARDX GlobeNewswire
Nov-07	Real-World Evidence Studies of XPHOZAH (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week ARDX GlobeNewswire
Nov-05	Ardelyx to Participate at the Jefferies Global Healthcare Conference in London ARDX GlobeNewswire
Nov-04	Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference ARDX GlobeNewswire
Oct-30	Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update ARDX GlobeNewswire
Oct-28	Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA (tenapanor) at the American College of Gastroenterology's 2025 Annual Meeting ARDX GlobeNewswire
Oct-21	Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney Week ARDX GlobeNewswire
Oct-13	Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025 ARDX GlobeNewswire
Oct-13	Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer ARDX GlobeNewswire
Aug-25	Ardelyx to Participate in Upcoming Investor Conferences ARDX GlobeNewswire
Aug-04	Ardelyx Announces Changes to the Executive Leadership Team ARDX GlobeNewswire
Aug-04	Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update ARDX GlobeNewswire
Jul-21	Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025 ARDX GlobeNewswire
Jun-02	Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer ARDX GlobeNewswire
May-21	Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025 ARDX GlobeNewswire
May-06	Ardelyx Presents Data Supporting IBSRELA (tenapanor) at Digestive Disease Week 2025 Conference ARDX GlobeNewswire
May-01	Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update ARDX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.